دورية أكاديمية
[Iatrogenic lung diseases].
العنوان: | [Iatrogenic lung diseases]. |
---|---|
المؤلفون: | Karoli NA, Rebrov AP, Roshchina AA, Steshenko RN, Bukiia AS |
المصدر: | Klinicheskaia meditsina [Klin Med (Mosk)] 2012; Vol. 90 (4), pp. 70-2. |
نوع المنشور: | Case Reports; English Abstract; Journal Article |
اللغة: | Russian |
بيانات الدورية: | Publisher: Med. informat︠s︡ionnoe agentstvo Country of Publication: Russia (Federation) NLM ID: 2985204R Publication Model: Print Cited Medium: Print ISSN: 0023-2149 (Print) Linking ISSN: 00232149 NLM ISO Abbreviation: Klin Med (Mosk) Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Moskva : Med. informat︠s︡ionnoe agentstvo Original Publication: Moskva. |
مواضيع طبية MeSH: | Iatrogenic Disease*, Lung Diseases/*etiology , Methotrexate/*adverse effects, Adult ; Crohn Disease/drug therapy ; Crohn Disease/pathology ; Enzyme Inhibitors/adverse effects ; Humans ; Lung Diseases/pathology ; Male ; Young Adult |
مستخلص: | The interest in iatrogenic diseases in general and those of lungs in particular is due to the possibility of elucidating and eliminating their etiological factors for the prevention of progression of pathological changes. However, diagnostics of such conditions is hampered by the lack of their specific clinical and morphological manifestations. The present study considers the relationship between interstitial lung lesions and the use of high doses of melothrexate (30 mg/week) for the treatment of Crohn's disease. The authors emphasize the necessity of regular monitoring the state of the respiratory system in metothrexate-treated patients and vigilance over the risk of alveolitis in such patients. The awareness of the patients of the possible side effects of metothrexate therapy is of primary importance. |
المشرفين على المادة: | 0 (Enzyme Inhibitors) YL5FZ2Y5U1 (Methotrexate) |
تواريخ الأحداث: | Date Created: 20120818 Date Completed: 20121003 Latest Revision: 20131121 |
رمز التحديث: | 20221213 |
PMID: | 22896987 |
قاعدة البيانات: | MEDLINE |
تدمد: | 0023-2149 |
---|